MedRx Co., Ltd (4586.T)
JPY 84.0
(-3.45%)
JPY 84.0
(-3.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -913 Million | -1.07 Billion | -923.68 Million | -985.35 Million | -1.54 Billion |
| Net Income | -932 Million | -1.1 Billion | -1.05 Billion | -1.1 Billion | -1.61 Billion |
| Depreciation & Amortization | 45 Million | 46.41 Million | 60.33 Million | 55.84 Million | 40.17 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | 5.24 Million | 8.26 Million | 7.24 Million | - |
| Change in working capital | 30 Million | -388 Thousand | 73.58 Million | 2.12 Million | 34.83 Million |
| Other non-cash items | -56 Million | -13.95 Million | -12.35 Million | 90.83 Million | -21.24 Million |
| Investing Cash Flow | -759 Thousand | -1.95 Million | -2.54 Million | -5.09 Million | -252.34 Million |
| Investments in PPE | -759 Thousand | -1.95 Million | -2.54 Million | -39.39 Million | -252.56 Million |
| Acquisitions | - | - | - | - | 220 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | 34 Million | - |
| Financing Cash Flow | 1.63 Billion | 356.31 Million | 815.91 Million | 1.39 Billion | 1.41 Billion |
| Debt repayment | - | - | -50 Million | -50 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 1.63 Billion | 352.13 Million | 851.02 Million | 1.33 Billion | 1.41 Billion |
| Other Financing Activities | 1.63 Billion | 4.18 Million | 14.89 Million | 6.31 Million | 2.44 Million |
| Accounts receivables | -17.77 Million | 7.77 Million | 14.12 Million | -2.11 Million | -6.65 Million |
| Accounts payables | - | - | - | - | -58 Thousand |
| Inventory | -1 Million | 3.44 Million | 8.12 Million | -1.03 Million | 23.55 Million |
| Other working capital | 31 Million | -45 Million | 7 Million | 72 Million | 6 Million |
| Cash at beginning of period | 994.02 Million | 1.7 Billion | 1.81 Billion | 1.41 Billion | 1.79 Billion |
| Cash at end of period | 1.72 Billion | 994.02 Million | 1.7 Billion | 1.81 Billion | 1.41 Billion |
| Capital Expenditure | -759 Thousand | -1.95 Million | -2.54 Million | -39.39 Million | -252.56 Million |
| Effect of forex changes on cash | 1 Million | 9.31 Million | 1.59 Million | -1.62 Million | -1.3 Million |
| Net cash flow / Change in cash | 726.69 Million | -709.61 Million | -108.71 Million | 401.56 Million | -386.08 Million |
| Free Cash Flow | -913.75 Million | -1.07 Billion | -926.23 Million | -1.02 Billion | -1.79 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 67 Million | -128 Million | -261 Million | -932.89 Million | -190 Million | -191 Million |
| Depreciation & Amortization | - | - | - | 45.56 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -29.96 Million | - | - |
| Other non-cash items | -67 Million | 128 Million | 261 Million | 114.13 Million | 190 Million | 191 Million |
| Investing Cash Flow | - | - | - | -759 Thousand | - | - |
| Investments in PPE | - | - | - | -759 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | 1.63 Billion | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.63 Billion | - | - |
| Other Financing Activities | - | - | - | 1.74 Million | - | - |
| Accounts receivables | - | - | - | -17.77 Million | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | -1.73 Million | - | - |
| Other working capital | - | - | - | -10.45 Million | - | - |
| Cash at beginning of period | - | - | - | 994.02 Million | - | - |
| Cash at end of period | - | - | - | 1.72 Billion | - | - |
| Capital Expenditure | - | - | - | -759 Thousand | - | - |
| Effect of forex changes on cash | - | - | - | 1 Million | - | - |
| Net cash flow / Change in cash | - | - | - | 726.69 Million | - | - |
| Free Cash Flow | - | - | - | -914.55 Million | - | - |
6235
9951
600255
3625
SYBX
PITAW